U.S. Water Utilities Stock News

PDF Solutions recently reported that increasing complexity in semiconductor manufacturing, rising 3D manufacturing investment, and growing use of its Exensio analytics, SecureWISE, and Cimetrix software are supporting stronger demand for its data and connectivity platforms. An interesting angle is the integration of Intel’s Tiber AI Studio into Exensio, which deepens PDF Solutions’ role in AI-driven semiconductor manufacturing workflows. We will now examine how the integration of Intel’s...

PulteGroup recently experienced a short-term pullback as investors reacted to past guidance for softer near-term earnings, a shrinking backlog, and an increasingly competitive homebuilding landscape ahead of its late-January 2026 earnings report. The tension between cautious expectations for order trends and profitability and some research pointing to strong balance sheet resilience and operational strength has left the market weighing near-term risks against longer-term potential. Against...

Everest Group, Ltd. has appointed Christopher Kujawa as Executive Vice President and Chief Human Resources Officer, effective January 20, 2026, succeeding interim CHRO Gail Van Beveren, who is staying briefly to support a smooth transition. Kujawa’s track record leading large-scale HR transformation at financial and technology-enabled services firms suggests Everest is reinforcing its focus on workforce effectiveness and long-term value creation through human capital. Next, we’ll explore how...

Some Applied Digital Corporation ( NASDAQ:APLD ) shareholders may be a little concerned to see that the Chairman...

Despite an already strong run, MACOM Technology Solutions Holdings, Inc. ( NASDAQ:MTSI ) shares have been powering on...

AtriCure (ATRC) recently issued a preliminary earnings update that pointed to a shift toward full year profitability in 2026, supported by guidance for revenue growth in the double digits and stronger adjusted EBITDA. See our latest analysis for AtriCure. The recent guidance and credit agreement amendment came after a sharp move higher around the earnings pre announcement. Yet the 1 year total shareholder return of 1.53% and 5 year total shareholder return of a 33.00% decline suggest only...

Getty Realty Corp. recently announced the detailed allocation of its 2025 common stock dividend distributions totaling US$1.88 per share, outlining how each of the four quarterly US$0.47 payments will be reported for tax purposes across ordinary income, capital gains, non-dividend distributions, and unrecaptured Section 1250 income. Alongside this, the company highlighted entering 2026 with full portfolio occupancy, strong rent collection, and over US$235 million of 2025 investment activity,...

In early January 2026, MoonLake Immunotherapeutics reported that the FDA had provided positive Type B meeting feedback, allowing a Biologics License Application for sonelokimab in hidradenitis suppurativa to proceed in the second half of 2026 using existing MIRA, VELA-1 and VELA-2 trial data without additional HS trials. An important nuance is that while the FDA accepted the overall evidence package and emphasized inclusion of VELA-2 for safety, it ruled out using mechanistic data plus a...

Revvity (RVTY) has given investors two fresh data points to assess: new 2025 revenue guidance pointing to mid single digit growth and a collaboration with Eli Lilly that brings AI models into its Signals platform. See our latest analysis for Revvity. Revvity's shares have rebounded in the short term, with a 30 day share price return of 16.9% and a 7 day gain of 8.29%. However, longer term total shareholder returns remain weak, including a 1 year total shareholder return decline of 4.71%,...

With no single headline event driving attention today, investors are watching WaterBridge Infrastructure (WBI) following recent price swings and mixed return patterns over the past week, month, and past three months. See our latest analysis for WaterBridge Infrastructure. Over the year to date, WaterBridge Infrastructure’s share price has moved to $21.55, with a 7 day share price return of 6.89% and a 90 day share price return of an 11.75% decline, which suggests recent momentum has cooled...

In early January 2026, Apprise by Walker & Dunlop launched a national HUD/FHA multifamily valuation and market study practice group, led by industry veteran Nelson Pratt, MAI, while Walker & Dunlop also formed a US$250 million affordable housing bridge-lending joint venture with Pretium and arranged a US$112.5 million hotel refinancing in Brooklyn. This cluster of initiatives signals a deeper push into HUD-insured and affordable multifamily housing services, potentially reinforcing Walker &...

Event context and recent share performance Collegium Pharmaceutical (COLL) has drawn attention after recent trading, with the share price at US$45.60 and returns showing a 2.8% decline over the past day and 5.3% decline over the past week. See our latest analysis for Collegium Pharmaceutical. While the recent 1 day and 7 day share price returns are negative, the 90 day share price return of 28.96% and 1 year total shareholder return of 36.73% suggest momentum has been building over a longer...

Expro Group Holdings (XPRO) has come into focus after mixed analyst actions, with Goldman Sachs reaffirming a Hold rating while Piper Sandler moved the stock to Underweight from Neutral, sending investors back to the fundamentals. See our latest analysis for Expro Group Holdings. After the analyst moves, Expro Group Holdings' share price of $16.21 comes after a 7 day share price return of 12.34% and a 30 day share price return of 24.98%. Its 1 year total shareholder return of 9.31% contrasts...

In January 2026, Health-E Commerce, parent of FSA Store and HSA Store, announced a collaboration with WEX to integrate its eligible-expense-only marketplaces into the WEX benefits portal, giving account holders single sign-on access, real-time balance visibility, and one-click DirectPay from their FSA/HSA funds. By embedding curated, IRS-compliant FSA/HSA shopping directly into its platform, WEX is tightening the link between benefits administration and everyday healthcare spending decisions...

In early January 2026, Zymeworks reported positive Phase 3 HERIZON-GEA-01 results for its HER2-targeted therapy Ziihera in advanced gastroesophageal adenocarcinoma, alongside a series of leadership changes including new board and executive appointments and key retirements. A distinctive angle in this news is that the HERIZON-GEA-01 data could unlock up to US$440.0 million in potential approval-related milestones for Ziihera across the US, Europe, Japan, and China, adding financial...

As the U.S. market grapples with rising Treasury yields and uncertainty surrounding Federal Reserve decisions, investors are keenly observing potential opportunities amid recent index declines. In this environment, identifying undervalued stocks can be crucial for those looking to capitalize on discrepancies between market price and estimated value, as these stocks might offer growth potential despite broader economic challenges.

As U.S. markets face weekly losses amid climbing Treasury yields, investors are increasingly focused on companies with strong fundamentals and insider confidence to navigate these uncertain times. In this landscape, growth companies with high insider ownership stand out, as they often signal management's belief in the firm's potential and align interests between executives and shareholders.

As the U.S. markets grapple with recent declines and rising Treasury yields, investors are keenly observing potential opportunities in various sectors. Penny stocks, while often seen as relics of past market trends, continue to offer intriguing possibilities for those willing to explore smaller or newer companies at accessible price points. By focusing on solid financials and growth potential, these stocks can present unique opportunities for investors looking to tap into under-the-radar...

As the U.S. market grapples with rising Treasury yields and a cautious Federal Reserve outlook, small-cap stocks are navigating a landscape marked by both challenges and opportunities. In this environment, identifying promising small caps requires a keen eye for companies with robust fundamentals that can weather economic fluctuations and capitalize on niche market demands.

The recent 11% drop in AIFU Inc.'s ( NASDAQ:AIFU ) stock could come as a blow to insiders who purchased CN¥12.3m worth...

We're definitely into long term investing, but some companies are simply bad investments over any time frame. It hits...

In recent days, multiple research firms, including Barclays and Evercore ISI, have reiterated coverage on Werner Enterprises while revising their views on the company’s prospects and positioning in the trucking and logistics market. The mix of “Hold” and “Underperform” ratings alongside more optimistic outlooks highlights how differently analysts interpret Werner’s operational trajectory and profitability challenges. We’ll now examine how this broad reassessment by major analysts could...

In recent days, Scotiabank and several other research firms shifted their views on American Homes 4 Rent, updating ratings and reassessing their outlook on the single‑family rental REIT. This cluster of analyst actions offers fresh information on how the market is reassessing American Homes 4 Rent’s risk‑reward profile and business outlook. Next, we’ll examine how this wave of analyst rating changes could influence American Homes 4 Rent’s investment narrative and future expectations. Rare...

Oruka Therapeutics (ORKA) drew fresh investor attention after reporting encouraging interim Phase 1 data for ORKA-002, highlighting a long half-life and sustained IL-17 inhibition that could support less frequent dosing in psoriasis and hidradenitis suppurativa. See our latest analysis for Oruka Therapeutics. The positive ORKA-002 readout and recent conference presence appear to have kept interest high, with a 1-day share price return of 2.77% and year to date share price return of 18.15%...